Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 106 AL 120

Frontal aperiodic activity and sensorimotor theta clustering are differentially modulated by tDCS during proprioceptive training in Parkinson's disease: An EEG study

Heydarpour H, Ashtiani MN, Bahrpeyma F, Tafakhori A.

Neuroscience. 2026 Nov 28;617:154-161. doi: 10.1016/j.neuroscience.2026.10.005. Epub 2026 Oct 5.

Targeting the temporal architecture of movement in Parkinson's disease

Pauletti C, Suppa A.

Clin Neurophysiol. 2026 Oct 3:2112422. doi: 10.1016/j.clinph.2026.2112422. Online ahead of print.

The Role of Mast Cells and Their Potential as a Therapeutic Target For Neuroinflammation

Scuderi SA, Basilotta R, Cucinotta L, Ardizzone A, Esposito E.

J Inflamm Res. 2026 Sep 29;19:540890. doi: 10.2147/JIR.S540890. eCollection 2026.

Does genetic testing remain relevant in advanced Parkinson's disease?

Westenberger A, Endaya NJ, Brüggemann N.

J Neural Transm (Vienna). 2026 Oct 6. doi: 10.1007/s00702-026-03295-w. Online ahead of print.

[Potential role of CHI3L1 in ischemic stroke - a neuroinflammatory or neuroprotective factor?]

Klachacz A, Malik A.

Postepy Biochem. 2026 Oct 6;72(3):201-210. doi: 10.18388/wht2rw10.

Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases

Tian Q, Tong Y, Yu F, Hu X.

CNS Neurosci Ther. 2026 Oct;32(10):e71118. doi: 10.1002/cns.71118.

A silent RAGE: The inflammatory pathway to dementia in Parkinson's disease

Peixoto DO, Gasparotto J, Ojo OR, Aro OP, Godswill US, de Abreu LF, Lopes LC, Moreira JCF, Gelain DP.

Ageing Res Rev. 2026 Oct 6;123:103392. doi: 10.1016/j.arr.2026.103392. Online ahead of print.

Beyond Histamine Blockade: Clemastine Fumarate as a Promoter of Myelin Regeneration, Inflammatory Regulation, and Neuroimmune Modulation in CNS Disorders

Singh RK, Banerjee C, Mehan S.

J Neuroimmune Pharmacol. 2026 Oct 7;21(1):51. doi: 10.1007/s11481-026-10321-x.

Large Language Model-Based Identification of Subjective Cognitive Decline in Electronic Health Records Among Older Adults With Normal Cognitive Testing: Retrospective Cohort Study

Wang L, Amariglio RE, Varghese S, Tian J, Seger D, Zhou L, Marshall GA.

JMIR Aging. 2026 Oct 7;9:e93011. doi: 10.2196/93011.

Tyrosine nitration: An emerging mechanistic landscape in neurodegeneration and cardiopulmonary disease

Adrita N, Claassen I, Huerta M, Black SM, Estevez AG, Roberts BR, Beckman JS, Franco MC.

Redox Biol. 2026 Nov;97:104423. doi: 10.1016/j.redox.2026.104423. Epub 2026 Oct 3.

Hyaluronic acid-based CeO₂ nanozymes for brain-targeted Parkinson's disease therapy: Biointerface design, multifunctional neuroprotective regulation and future perspectives: A review

Huang Q, Sun Y, Duan Y, Chen Y, Wang L, Wu X, Guan B, Liu C.

Int J Biol Macromol. 2026 Oct 7;384(Pt 1):154770. doi: 10.1016/j.ijbiomac.2026.154770. Online ahead of print.

Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits

Huang H, Ruan P, Wang Y, Liu Z, Wu Y, Zhang Z, Jiang X, Fu P.

Parkinsonism Relat Disord. 2026 Sep 28:109001. doi: 10.1016/j.parkreldis.2026.109001. Online ahead of print.

RVG29-functionalized nanocarriers for brain-targeted therapy of neurodegenerative diseases: mechanisms, therapeutic advances, and translational perspectives

Gandhi SM, Patel S, Haswani NG, Wahab S, Sabah ZU, Kapoor DU.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Oct 8. doi: 10.1007/s00210-026-05958-7. Online ahead of print.

Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation

Binder T, Hartig J, Sitzmann L, Ip CW, Capetian P, Lange F, Reich M, Daniels C, Volkmann J.

Mov Disord Clin Pract. 2026 Oct 8:10.1002/mdc3.70831. doi: 10.1002/mdc3.70831. Online ahead of print.

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ahmed AAO, Ahmed OAO, Dishean AS, Gilbert C, Elkheir MMAS, Sota HA, Abdulaziz MAM, Mahmoud EYM, Ahmed RAO.

Parkinsons Dis. 2026 Oct 6;2026:9352886. doi: 10.1155/padi/9352886. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias